Drugs and Therapy Perspectives : Impact Factor & More
eISSN: 1179-1977pISSN: 1172-0360
Share this on:
Key Metrics
CiteScore 
0.9
SJR
Q4Pharmacology (medical)
SNIP
0.19
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Drugs and Therapy Perspectives
Drugs and Therapy Perspectives Journal Specifications
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1993 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Drugs and Therapy Perspectives ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Drugs and Therapy Perspectives
Long‑term treatment with ivosidenib in IDH1‑mutant combined hepatocellular–cholangiocarcinoma: a case report
- 23 Oct 2026
- Drugs & Therapy Perspectives
Fluoroquinolone-Associated Injuries of Tendon, Muscles and Synovium: Recent Evidence From a Large German Claims Data Cohort Study
- 14 Sep 2026
- Drugs & Therapy Perspectives
Treat paediatric asthma with a personalised and stepwise approach
- 12 Sep 2026
- Drugs & Therapy Perspectives
Gepotidacin in uncomplicated urinary tract infections and uncomplicated urogenital gonorrhoea: a profile of its use
- 11 Sep 2026
- Drugs & Therapy Perspectives
Guselkumab in paediatric plaque psoriasis: a profile of its use
- 11 Sep 2026
- Drugs & Therapy Perspectives
Elinzanetant in moderate to severe menopausal vasomotor symptoms: a profile of its use
- 5 Sep 2026
- Drugs & Therapy Perspectives
Long‑term treatment with ivosidenib in IDH1‑mutant combined hepatocellular–cholangiocarcinoma: a case report
- 23 Oct 2026
- Drugs & Therapy Perspectives
Fluoroquinolone-Associated Injuries of Tendon, Muscles and Synovium: Recent Evidence From a Large German Claims Data Cohort Study
- 14 Sep 2026
- Drugs & Therapy Perspectives
Treat paediatric asthma with a personalised and stepwise approach
- 12 Sep 2026
- Drugs & Therapy Perspectives
Gepotidacin in uncomplicated urinary tract infections and uncomplicated urogenital gonorrhoea: a profile of its use
- 11 Sep 2026
- Drugs & Therapy Perspectives
Guselkumab in paediatric plaque psoriasis: a profile of its use
- 11 Sep 2026
- Drugs & Therapy Perspectives
Elinzanetant in moderate to severe menopausal vasomotor symptoms: a profile of its use
- 5 Sep 2026
- Drugs & Therapy Perspectives
FAQs on Drugs and Therapy Perspectives
How long has Drugs and Therapy Perspectives been actively publishing? 
What is the publishing frequency of Drugs and Therapy Perspectives?
How many articles did Drugs and Therapy Perspectives publish last year?
What is the eISSN & pISSN for Drugs and Therapy Perspectives?
What is Citescore for Drugs and Therapy Perspectives?
What is SNIP score for Drugs and Therapy Perspectives?
What is the SJR for Drugs and Therapy Perspectives?
Who is the publisher of Drugs and Therapy Perspectives?
